Catalyst Pharmaceuticals Inc
CPRX·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$31.51
Today
+0.0%
YTD
+35.3%
About
Healthcare firm Catalyst Pharmaceuticals develops and commercialises therapies for rare debilitating, neurological, and chronic neuromuscular diseases. Founded in 2002, the firm operates within the US and has headquarters in Coral Gables, Florida. Catalyst Pharmaceuticals stock has been assigned the ticker CPRX on the NASDAQ CM stock market. Track CPRX share price movements and get the most recent news on this stock by adding it to your eToro watchlist.
Price chart
Closing price history for CPRX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)18.09
P/S (TTM)6.69
P/B (TTM)3.80
Market cap$3.85B
Cap tierMid-cap
Industry avg P/E-43.27
Profitability
Gross margin79.62%
EBIT margin44.83%
Net margin42.66%
ROE24.50%
ROA21.52%
Earnings & Revenue
Revenue (TTM)$596.96M
Revenue growth (1Y)+11.7%
EPS (TTM)$1.74
Free cash flow$208.13M
Total debt$2.68M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.94
Employees182
Next earnings5 Aug '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.